Integer (ITGR) Projected to Post Earnings on Thursday

Integer (NYSE:ITGR) will likely be releasing its earnings data before the market opens on Thursday, February 20th. Analysts expect Integer to post earnings of $1.46 per share and revenue of $446.28 million for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Integer Trading Down 1.0 %

Shares of Integer stock opened at $137.30 on Thursday. Integer has a fifty-two week low of $94.56 and a fifty-two week high of $146.36. The firm has a market cap of $4.61 billion, a price-to-earnings ratio of 42.38, a price-to-earnings-growth ratio of 1.79 and a beta of 1.13. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. The business has a fifty day simple moving average of $137.89 and a 200-day simple moving average of $131.42.

Wall Street Analysts Forecast Growth

ITGR has been the topic of several research reports. Truist Financial upped their target price on Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. KeyCorp increased their price objective on Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Citigroup increased their price objective on Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a report on Wednesday, December 11th. Benchmark increased their price objective on Integer from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, October 21st. Finally, Piper Sandler reissued an “overweight” rating and set a $140.00 price objective (up previously from $125.00) on shares of Integer in a report on Friday, October 25th. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $146.56.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.